Access To Medicine Foundation

Often searched

Index ranking

Vacancies

10 year analysis

  • Healthcare inequity
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
  • Become a catalyst
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
  • Sectors and research
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Research hub
    • Company profiles & report cards
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Research hub
    • Company profiles & report cards
  • Cross-Sector Programmes
    • Antimicrobial resistance
    • Diabetes care
    • Antimicrobial resistance
    • Diabetes care
  • On the pulse of global health
    • Access insights
    • Health Equity through Her Lens
    • The Health Equity podcast
    • Access insights
    • Health Equity through Her Lens
    • The Health Equity podcast
  • News
  • Our team
  • Featured insights
  • Governance & financials
  • Vacancies
  • Media coverage
  • FAQ
  • Contact us

FT Global Pharmaceutical and Biotechnology Conference

On Monday 8 November 2021, Margo Warren will join the Financial Times' virtual Global Pharmaceutical and Biotechnology Conference to discuss pharma pipelines.

Date

08 November 2021

About the event
FT Live is the global conferences and events division of the Financial Times Group. This event, hosted virtually, will welcome over 2,000 attendees, feature over 50 speakers, and include more than 1,000 companies from around the globe. FT Live aims connect global executive audiences to each other while providing the latest in knowledge and opinion.

Session: "Pricing and market access trends"
Margo Warren, Head of Policy for the Foundation, will join the "Pricing and market access trends" session, hosted by Carole Longson, Life Sciences Adviser at NICE, to discuss topics including: 

  • What are the prospects for health policy and regulatory reforms around market access?

  • What could be the legacy of the pandemic in terms of standards and processes to support product approval?

  • How could the balance of power between pharma, payers, patients and other stakeholders shift in the next few years?

Please click here for a detailed agenda and more information. 

Access to Medicine Foundation

Interested in our work?

Access to Medicine Foundation is funded by

Terms & conditions

Privacy & cookie policy

Disclaimer

Copyright 2004 - 2025 Access to Medicine Foundation - All Rights Reserved